XML 42 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Operations Information
12 Months Ended
Dec. 31, 2023
Consolidated Statements of Operations Information  
Consolidated Statements of Operations Information

Note 17. Consolidated Statements of Operations Information

Revenue

The Group’s revenue comprised:

Years ended December 31:

    

2023

    

2022

    

2021

Royalty, goods and products and services

$

43,330

$

52,218

$

60,201

Interest

 

3,717

 

3,712

 

405

Dividends

146

268

244

Other, including medical and real estate sectors

7,751

7,491

10,441

Revenue

$

54,944

$

63,689

$

71,291

The revenue of $54,944 from royalty, goods and products and services for the year ended December 31, 2023 comprised royalty revenue of $35,234, natural gas of $3,374, power and electricity of $3,557 and fees of $1,165.

The revenue of $52,218 from royalty, goods and products and services for the year ended December 31, 2022 comprised royalty revenue of $28,970, natural gas of $17,581, power and electricity of $3,974 and fees of $1,693.

The revenue of $60,201 from royalty, goods and products and services for the year ended December 31, 2021 comprised royalty revenue of $40,137, natural gas of $13,236, power and electricity of $2,927, food products of $2,721 and fees of $1,180.

Costs and Expenses

The Group’s costs of sales and services comprised:

Years Ended December 31:

    

2023

    

2022

    

2021

Royalty, goods and products and services

$

12,689

$

23,677

$

22,933

Reversal of write-down of inventories

(27)

(21)

(19)

Gain on derivative contracts, net

(1,376)

Net fair value loss (gain) on investment property and real estate for sale

59

(96)

(407)

Gain on disposition of a subsidiary

(264)

Gains on settlements and derecognition of liabilities

(1,313)

(69)

(390)

Change in fair value of loan payable measured at FVTPL

360

141

1,616

Losses on securities, net

2,794

2,436

2,320

Other, including medical and real estate sectors

4,512

4,078

6,241

Total costs of sales and services

$

19,074

$

29,882

$

30,918

Note 17. Consolidated Statements of Operations Information (continued)

The Group’s net gain on disposition of a subsidiary comprised:

Years ended December 31:

    

2023

    

2022

    

2021

Net liabilities in excess of considerations received

 

$

 

$

(273)

 

$

Reclassification adjustment for the exchange differences upon disposition of a subsidiary

9

Gain on disposition of a subsidiary (see Note 27)

 

$

 

$

(264)

 

$

The Group included the following items in costs of sales and services:

Years ended December 31:

    

2023

    

2022

    

2021

Inventories as costs of goods sold (including depreciation expenses allocated to costs of goods sold)

$

40

$

80

$

3,488

The Group’s selling, general and administrative expenses comprised:

Years ended December 31:

    

2023

    

2022

    

2021

Compensation (wages and salaries)

$

5,418

$

4,443

$

4,551

Legal and professional

 

7,242

 

6,983

6,395

Accounting

1,646

885

1,238

Consulting and fees

3,095

6,529

3,423

Depreciation and amortization

932

784

481

Office

804

748

948

Reimbursement of expenses (net of recovery)

886

5,607

1,018

Other

4,159

*

2,501

3,090

$

24,182

$

28,480

$

21,144

*Including expenses of $542 relating to a planned acquisition which was terminated in 2023.

Additional information on the nature of costs and expenses

Years Ended December 31:

    

2023

    

2022

    

2021

Depreciation, depletion and amortization

$

7,929

$

10,699

$

11,023

Employee benefits expenses*

 

8,057

 

7,194

 

6,922

Expenses for defined contribution plans and similar plans

227

278

253

Termination benefits

394

*Employee benefits expenses do not include the directors’ fees of the Company. For directors’ fees, see Note 24.